The American Journal of Medicine
Volume 119, Issue 7, Supplement 1 , Pages S54-S58 , July 2006

Nephrogenic Syndrome of Inappropriate Antidiuresis: A Novel Disorder in Water Balance in Pediatric Patients

References 

  1. Verbalis JG . Diabetes insipidus . Rev Endocr Metab Disord . 2003;4:177–185
  2. Feldman BJ , Rosenthal SM , Vargas GA , et al.   Nephrogenic syndrome of inappropriate antidiuresis . N Engl J Med . 2005;352:1884–1890
  3. Bartter FC , Schwartz WB . The syndrome of inappropriate secretion of antidiuretic hormone . Am J Med . 1967;42:790–806
  4. Robertson GL , Aycinena P , Zerbe RL . Neurogenic disorders of osmoregulation . Am J Med . 1982;72:339–353
  5. Morello JP , Bichet DG . Nephrogenic diabetes insipidus . Annu Rev Physiol . 2001;63:607–630
  6. Rosenthal W , Antaramian A , Gilbert S , Birnbaumer M . Nephrogenic diabetes insipidus (a V2 vasopressin receptor unable to stimulate adenylyl cyclase) . J Biol Chem . 1993;268:13030–13033
  7. Probst WC , Snyder LA , Schuster DI , Brosius J , Sealfon SC . Sequence alignment of the G-protein coupled receptor superfamily . DNA Cell Biol . 1992;11:1–20
  8. Hu J , Spiegel AM . Naturally occurring mutations of the extracellular Ca2+-sensing receptor (implications for its structure and function) . Trends Endocrinol Metab . 2003;14:282–288
  9. Spiegel AM , Weinstein LS . Inherited diseases involving G proteins and G protein-coupled receptors . Annu Rev Med . 2004;55:27–39
  10. Tanaka Y , Sugita K , Saito T , et al.   Impaired urinary water excretion in a three-generation family . Pediatr Nephrol. . 2001;16:820–822
  11. Almond CS , Shin AY , Fortescue EB , et al.   Hyponatremia among runners in the Boston Marathon . N Engl J Med . 2005;352:1550–1556
  12. Siegel AJ . Exercise-associated hyponatremia (role of cytokines) . Am J Med. . 2006;119(Suppl 7A):S74–S78
  13. Hirsch AT , Dzau VJ , Majzoub JA , Creager MA . Vasopressin-mediated forearm vasodilation in normal humans (evidence for a vascular vasopressin V2 receptor) . J Clin Invest . 1989;84:418–426
  14. Kaufmann JE , Iezzi M , Vischer UM . Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor- and cAMP-mediated signaling . J Thromb Haemost . 2003;1:821–828
  15. Mannucci PM , Ruggeri ZM , Pareti FI , Capitanio A . 1-Deamino-8-d-arginine vasopressin (a new pharmacological approach to the management of haemophilia and von Willebrands’ diseases) . Lancet . 1977;1:869–872
  16. Bichet DG , Razi M , Lonergan M , et al.   Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus . N Engl J Med . 1988;318:881–887
  17. Verbalis JG . Vasopressin V2 receptor antagonists . J Mol Endocrinol . 2002;29:1–9
  18. Morin D , Cotte N , Balestre MN , et al.   The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities . FEBS Lett . 1998;441:470–475
  19. Huang EA , Feldman BJ , Schwartz ID , Geller DH , Rosenthal SM , Gitelman SE . Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children . J Pediatr . 2006;148:128–131
  20. Decaux G , Prospert F , Penninckx R , Namias B , Soupart A . Five-year treatment of the chronic syndrome of inappropriate secretion of ADH with oral urea . Nephron . 1993;63:468–470

PII: S0002-9343(06)00494-3

doi: 10.1016/j.amjmed.2006.05.008

The American Journal of Medicine
Volume 119, Issue 7, Supplement 1 , Pages S54-S58 , July 2006

Article Tools

* Image Usage & Resolution